Search company, investor...


Founded Year



Acquired | Acquired

Total Raised




About Nura

Nura is a development stage biotechnology company focused on the discovery of therapeutics for behavioral disorders.

Headquarters Location

1420 Fifth Avenue Suite 2600

Seattle, Washington, 98101,

United States


Missing: Nura's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Nura's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Nura

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nura is included in 1 Expert Collection, including Conference Exhibitors.


Conference Exhibitors

6,062 items

Companies that will be exhibiting at CES 2018

Nura Patents

Nura has filed 13 patents.

The 3 most popular patent topics include:

  • Audio engineering
  • Audio equipment manufacturers
  • Acoustics
patents chart

Application Date

Grant Date


Related Topics




Audio engineering, Acoustics, Loudspeakers, Hearing, Audio equipment manufacturers


Application Date


Grant Date



Related Topics

Audio engineering, Acoustics, Loudspeakers, Hearing, Audio equipment manufacturers



Latest Nura News

Nura Frequently Asked Questions (FAQ)

  • When was Nura founded?

    Nura was founded in 2003.

  • Where is Nura's headquarters?

    Nura's headquarters is located at 1420 Fifth Avenue, Seattle.

  • What is Nura's latest funding round?

    Nura's latest funding round is Acquired.

  • How much did Nura raise?

    Nura raised a total of $16.7M.

  • Who are the investors of Nura?

    Investors of Nura include Omeros, Linkagene, Cercano Management, Novartis Venture Funds, Venture Associates and 19 more.

  • Who are Nura's competitors?

    Competitors of Nura include Cerecin, Checkpoint Surgical, Oxurion, Orexigen Therapeutics, CureTech and 12 more.

Compare Nura to Competitors

Quantum Immunologics

Quantum Immunologics, Inc. ("QI") is a research-driven biotechnology company that is working on discoveries in immunotherapy science. QI is dedicated to the research, development and production of technologies that focus on the treatments and diagnoses of cancer and other diseases related to the immune system. Leveraging an expansive pipeline of biopharmaceutical innovations, QI remains committed to advancing medicine with the ultimate goal of dramatically improving lives.

Bio3 Research

nnBio3 Research s.r.l. is a private biopharmaceutical company based in Milan, Italy, with a USA subsidiary, Bio3 Research Inc., based in Hayward/CA. Bio3 Research develops new compounds up to IND stage with potential in cardiovascular field. The company is focused in the area of cardiovascular disorders related to HMGB1 (High Mobility Group Box 1) over-expression.


Kaperio is a biopharmaceutical company focused on cardiovascular disease.

Janus Pharmaceuticals

Janus Pharmaceuticals Inc. (Janus) is a specialty pharmaceutical company identifying, acquiring and aggressively developing topical prescription products for treatment of skin infections. Determined to be the "Dermal Alternative", Janus has already established a strong intellectual property portfolio for topical anti-infective compounds that would be rapidly commercialized through fast regulatory pathways. Led by an accomplished management team and board located in the US and Japan, Janus has trans-Pacific network and resources in the biopharmaceutical industry.

Checkpoint Surgical Logo
Checkpoint Surgical

Checkpoint Surgical provides surgeons with neurodevices to preserve nerves and evaluate nerve and muscle excitability in surgical procedures for better patient outcomes. Checkpoint Surgical launched the CHECKPOINT Stimulator/Locator as its flagship product in a line of neuromuscular surgical devices.


Hunter-Fleming is a biopharmaceutical company developing new medicines to treat neurological and cardiovascular disorders. The company focus is on unmet patient needs in dementias such as Alzheimer's disease, as well as other important conditions such as neuropathic pain, head and spinal cord injuries and myocardial infarction.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.